Analyst Reco. GoHealth, Inc.

Equities

GOCO

US38046W2044

Multiline Insurance & Brokers

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
1.790 ^USD	+1.99%		-10.05%	-16.74%

17/12	GoHealth Inc - to offer and sale, from time to time 9.6 million shares of class A common stock by selling stockholder - SEC filing	RE
19/11	William Blair Downgrades GoHealth to Market Perform From Outperform	MT

Analyst Reco.

26/11	RBC Cuts Price Target on GoHealth to $5 From $12, Keeps Sector Perform Rating	MT
19/11	William Blair Downgrades GoHealth to Market Perform From Outperform	MT
28/25/28	RBC Cuts Price Target on GoHealth to $12 From $18, Keeps Sector Perform Rating	MT
20/24/20	RBC Cuts Price Target on GoHealth to $13 From $20, Notes 'Diminished Topline Visibility' in Near Term; Sector Perform Kept	MT
14/23/14	RBC Raises PT on GoHealth to $20 From $15 After 'Solid' Q2 Results, Says Encompass Gains Momentum Ahead of Annual Enrollment Period; Sector Perform Kept	MT
12/23/12	RBC Raises Price Target on GoHealth to $15 From $14, Maintains Sector Perform Rating	MT
04/23/04	Credit Suisse Raises GoHealth's Price Target to $8.50 From $7 After Model Update; Keeps Underperform Rating	MT
17/23/17	RBC Cuts Price Target on GoHealth to $14 From $15 After Q4 Miss Amid Negative Revenue Lookback Adjustment; Sector Perform Kept	MT
23/22/23	Credit Suisse Adjusts GoHealth's Price Target to $7 From $18.75, Retains Underperform Rating	MT
26/22/26	RBC Capital Adjusts GoHealth's Price Target to $1 From $2, Maintains Sector Perform Rating	MT
16/22/16	Evercore ISI Adjusts GoHealth's Price Target to $1.75 from $4.50, Keeps In Line Rating	MT
16/22/16	Morgan Stanley Adjusts GoHealth Price Target to $1 From $3, Maintains Equalweight Rating	MT
03/22/03	RBC Downgrades GoHealth to Sector Perform From Outperform, Slashes Price Target to $2 From $10, Citing 'Sea Change in Operating Backdrop'	MT
02/22/02	Truist Securities Downgrades GoHealth to Hold from Buy, Lowers Price Target to $2 From $6	MT
18/22/18	Barclays Adjusts Price Target for GoHealth to $3 From $5, Maintains Equalweight Rating	MT
07/22/07	Credit Suisse Downgrades GoHealth to Underperform from Neutral, Says Among Potential M&A Targets; Lowers PT to $3 from $6	MT
05/22/05	BofA Securities Double Downgrades GoHealth to Underperform from Buy, Adjusts Price Target to $3.50 from $7.50; Shares Drop 12%	MT
05/22/05	Evercore ISI Lowers Price Target for GoHealth to $4.50 From $7.50, Maintains In-Line Rating	MT
11/21/11	Morgan Stanley Adjusts Price Target on GoHealth to $5.50 from $13, Keeps Equalweight Rating	MT
11/21/11	Truist Lowers Price Target for GoHealth to $6 From $11, Maintains Buy Rating	MT
10/21/10	RBC Cuts Price Target on GoHealth to $10 From $17, Citing Sector Rerating, Maintains Outperform Rating	MT
09/21/09	Barclays Downgrades GoHealth to Equalweight from Overweight, Adjusts Price Target to $5 from $10	MT
13/21/13	GOHEALTH : Barclays Adjusts GoHealth's Price Target to $10 from $18, Keeps Overweight Rating	MT
12/21/12	GOHEALTH : Credit Suisse Downgrades GoHealth to Neutral from Outperform on Q2 EBITDA Miss, Reduced 2021 EBITDA Outlook; Lowers PT to $10 from $18	MT
12/21/12	GOHEALTH : Receives Cut to Price Target From RBC to $17 From $20, Shares Fall Pre-Bell After Q2 EBITDA Miss; Outperform Kept	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Analyst Reco. GoHealth, Inc.

Equities

GOCO

US38046W2044

Multiline Insurance & Brokers

Analyst Reco.

Filters